These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 832516)

  • 41. [Tissue levels of fosfomycin and tobramycin in the rat kidney].
    Savoia D; Fontana G; Di Carlo R
    G Ital Chemioter; 1976; 23(1):9-10. PubMed ID: 1029697
    [No Abstract]   [Full Text] [Related]  

  • 42. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 43. The passage of fosfomycin into the cerebrospinal fluid in children's meningitis.
    Llorens J; Lobato A; Olay T
    Chemotherapy; 1977; 23 Suppl 1():189-95. PubMed ID: 832514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New studies on placental transfer of fosfomycin.
    Ferreres L; Paz M; Martín G; Gobernado M
    Chemotherapy; 1977; 23 Suppl 1():175-9. PubMed ID: 832512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis.
    Bustamante J; Martin Mateo MC; De Paula de Pedro A; Ortiz Manchado O
    Nephron; 1978; 22(4-6):312-5. PubMed ID: 740091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Blood 17-hydroxycorticosteroids and their elimination during hemodialysis in acute and chronic renal insufficiency].
    Timokhov VS; Ryzhenko VM; Shaposhnikova VV
    Ter Arkh; 1976; 48(10):99-104. PubMed ID: 1024286
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical experience with fosfomycin sodium for bacterial infections in obstetrics and gynecology].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1983 Aug; 36(8):2109-14. PubMed ID: 6655828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Update on antibiotic therapy. 15) A combination of fosfomycin and amoxicillin (penamic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 Mar; 74(13):769-74. PubMed ID: 6835564
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):739-41. PubMed ID: 3309806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G; Malandain H; Acar J; Fillastre JP
    Nouv Presse Med; 1972 May; 1(21):1438. PubMed ID: 5036700
    [No Abstract]   [Full Text] [Related]  

  • 51. Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling.
    Parker SL; Roberts JA; Lipman J; Wallis SC
    Bioanalysis; 2015 Oct; 7(19):2585-95. PubMed ID: 26470832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney.
    Verhoef J; Oe PL; Simonian S
    Antonie Van Leeuwenhoek; 1973 Nov; 39(4):654. PubMed ID: 4543761
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.
    Barbanoj M; Antonijoan R; Morte A; Grinyó JM; Solà R; Vallès J; Peraire C; Cordero JA; Muñoz A; Jané F; Obach R
    Clin Pharmacol Ther; 1999 Nov; 66(5):485-91. PubMed ID: 10579475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Plasma aldosterone in chronic renal insufficiency and in anephric patients (author's transl)].
    Botey A; Bestard J; Mauri M; López Pedret J; Revert L
    Med Clin (Barc); 1979 Jul; 73(3):94-102. PubMed ID: 470511
    [No Abstract]   [Full Text] [Related]  

  • 55. Fosfomycin in treatment of respiratory bacterial infections.
    Bonora V; Lozano C; Santos M; Paz M; Baguena J; Gobernado M
    Chemotherapy; 1977; 23 Suppl 1():337-41. PubMed ID: 832534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diffusion of fosfomycin into bone tissue in man].
    Sirot J; Lopitaux R; Dumont C; Rampon S; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):522-4. PubMed ID: 6348661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxicological studies on fosfomycin-Na salt. I. Acute toxicity in mice and rats (author's transl)].
    Koeda T; Odaki M; Sasaki H; Yokota M; Watanabe H; Kawaoto H; Ito T; Ishiwatari N
    Jpn J Antibiot; 1979 Jan; 32(1):61-6. PubMed ID: 423368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fosfomycin in the bacteriuria of paraplegic patients.
    Martínez J; Mendoza J
    Chemotherapy; 1977; 23 Suppl 1():275-80. PubMed ID: 832525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of phosphomycin during haemofiltration.
    Fernandez Lastra C; Mariño EL; Dominguez-Gil A; Tabernero JM; Grande Villoria J
    Br J Clin Pharmacol; 1984 Apr; 17(4):477-80. PubMed ID: 6372842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.